Based on our previous report showing the potential of EMT and metastasis-promoting effects of DPP-4 inhibitors, which are widely prescribed drugs to treat diabetes, we tested whether DPP-4 inhibitors could induce chemoresistance in breast cancer cells. Here, DPP4 is linked to breast carcinoma.